DK347189D0 - Levende vaccine mod newcastle disease - Google Patents

Levende vaccine mod newcastle disease

Info

Publication number
DK347189D0
DK347189D0 DK347189A DK347189A DK347189D0 DK 347189 D0 DK347189 D0 DK 347189D0 DK 347189 A DK347189 A DK 347189A DK 347189 A DK347189 A DK 347189A DK 347189 D0 DK347189 D0 DK 347189D0
Authority
DK
Denmark
Prior art keywords
newcastle disease
live vaccine
cncm
log
deposited
Prior art date
Application number
DK347189A
Other languages
English (en)
Other versions
DK175318B1 (da
DK347189A (da
Inventor
Nico Van Wiltenburg
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of DK347189D0 publication Critical patent/DK347189D0/da
Publication of DK347189A publication Critical patent/DK347189A/da
Application granted granted Critical
Publication of DK175318B1 publication Critical patent/DK175318B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK198903471A 1988-07-18 1989-07-13 Levende vaccine mod Newcastle disease-virusstamme og anvendelse af stammen DK175318B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8801819 1988-07-18
NL8801819 1988-07-18

Publications (3)

Publication Number Publication Date
DK347189D0 true DK347189D0 (da) 1989-07-13
DK347189A DK347189A (da) 1990-01-19
DK175318B1 DK175318B1 (da) 2004-08-16

Family

ID=19852645

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198903471A DK175318B1 (da) 1988-07-18 1989-07-13 Levende vaccine mod Newcastle disease-virusstamme og anvendelse af stammen

Country Status (9)

Country Link
US (1) US5149530A (da)
EP (1) EP0351908B1 (da)
JP (1) JP2655726B2 (da)
AT (1) ATE112490T1 (da)
DE (1) DE68918649T2 (da)
DK (1) DK175318B1 (da)
ES (1) ES2060740T3 (da)
HU (1) HU204439B (da)
IE (1) IE65736B1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250298A (en) * 1988-10-07 1993-10-05 University Of Delaware Live attenuated newcastle disease virus vaccines and preparation thereof
FR2682966B1 (fr) * 1991-10-29 1994-12-02 Rhone Merieux Preparation d'antigenes et de vaccins du virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
CA2181862C (en) * 1995-08-01 2009-12-22 Carla Christina Schrier Mild newcastle disease virus vaccine
EP0770397B1 (en) * 1995-10-18 2004-04-21 Akzo Nobel N.V. Newcastle disease virus combination vaccine
EP0848956A1 (en) * 1996-12-17 1998-06-24 Dimminaco Ag/Sa/Ltd. In ovo vaccination against Newcastle Disease
TW200502402A (en) * 2002-12-06 2005-01-16 Wyeth Corp Escape mutants of newcastle disease virus as marker vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798835A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Newcastle disease and infectious bronchitis vaccines and production thereof
US3876763A (en) * 1970-12-29 1975-04-08 Shionogi & Co Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines
BE853923A (fr) * 1977-04-25 1977-10-25 Rit Rech Ind Therapeut Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation
EP0009277B1 (en) * 1978-09-14 1984-04-18 Gist-Brocades N.V. Combined vaccine active against newcastle disease and egg production drop caused by adeno-like viruses, process for preparing it, adeno-like and newcastle disease virus strains
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц

Also Published As

Publication number Publication date
EP0351908B1 (en) 1994-10-05
DE68918649T2 (de) 1995-03-23
JPH0269422A (ja) 1990-03-08
JP2655726B2 (ja) 1997-09-24
US5149530A (en) 1992-09-22
ES2060740T3 (es) 1994-12-01
IE65736B1 (en) 1995-11-15
IE892284L (en) 1990-01-18
EP0351908A1 (en) 1990-01-24
DK175318B1 (da) 2004-08-16
DE68918649D1 (de) 1994-11-10
ATE112490T1 (de) 1994-10-15
HUT52703A (en) 1990-08-28
DK347189A (da) 1990-01-19
HU204439B (en) 1992-01-28

Similar Documents

Publication Publication Date Title
ES2095355T3 (es) Material transparente para usos dentales.
ATE103180T1 (de) Impfstoff-zubereitung.
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
DK486587A (da) Gen, kodende for humane kolonistimulerende faktorer
IL78913A (en) Synthetic vaccines for foot and mouth disease,their preparation and use
NO904342L (no) Fiskevaksine omfattende en virulent, inntrengende bakterie
EP0400076A4 (en) A synthetic antigen evoking anti-hiv response
DE3882599D1 (de) Hundecoronavirus-impfstoff.
DK347189A (da) Levende vaccine mod newcastle disease
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
CA2273074A1 (en) In ovo vaccination against newcastle disease
FR2580176B1 (fr) Vaccin antirabique avirulent
DE3681229D1 (de) Impfstoffe fuer einen tag alte huehner gegen die infektioese bronchitis.
ES2058570T3 (es) Procedimiento para la obtencion de una vacuna antirrabica no virulenta.
IT1276509B1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
ATE84722T1 (de) Tollwut-lebendimpfstoff.
IT210095Z2 (it) Poltrona odontoiatrica per paziente conimbottitura asportabile.
IT8622348A0 (it) 2-bromo,1',2',-dicloro-perfluoro dietil-etere e procedimento per lasua preparazione.
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
Felfe et al. Trends in production of foot-and-mouth disease vaccine.
AU7384387A (en) Avirulent bacterial strains used in live vaccine preparation
NO901231D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
AU6725387A (en) Drugs for the treatment and cure of all infectious diseases caused by pathogenic virulent micro-organisms

Legal Events

Date Code Title Description
PUP Patent expired